learndrugs
Mental & Behavioral Health

Schizophrenia & Psychotic Disorders

High-yield Verified · Sep 2026

Schizophrenia is a psychotic disorder requiring two or more characteristic symptoms — at least one being delusions, hallucinations or disorganized speech — present for a significant portion of one month, within at least six months of continuous illness and functional decline.

The disorder behind positive versus negative symptoms, the four dopamine pathways, the 1-month-inside-6-months duration rule, the command-hallucination question, the AIMS screen, and the oculogyric crisis that arrives 36 hours after the first dose.

What’s going wrong in the body

The normal physiology, where it fails, and why the body’s compensation backfires.

01 Three symptom categories, not two — and only one of them responds to drugs

Psychosis is the umbrella and schizophrenia is one disorder beneath it. Psychosis itself is "an amalgamation of psychological symptoms resulting in a loss of contact with reality" — the hallmark of the schizophrenia spectrum, but also a feature of mood and substance use disorders and of many neurologic and medical conditions. DSM-5-TR deliberately "strays from offering a hard definition of 'psychosis'" and instead defines psychotic disorders by abnormality in one of five domains: delusions, hallucinations, disorganized thought, disorganized behavior, and negative symptoms.

Positive symptoms are things added to mental functioning — "a distortion or excess of normal functions," including hallucinations, delusions, thought disorders, disorganized speech and altered behavior. Negative symptoms are the absence or decrease of normal behavior and emotional response: avolition (reduced motivation and difficulty planning, beginning and sustaining activities), anhedonia, flat affect (reduced expression through face or voice) and reduced speaking. Cognitive symptoms are the third category and not a footnote — problems in attention, concentration and memory, difficulty processing information to make decisions, and trouble using information immediately after learning it.

Why the three-way split is the most clinically important thing on this page: although diagnosis and treatment "primarily emphasize psychotic symptoms," it is the negative and cognitive symptoms that "play a significant role in impairing social and occupational functioning and often show limited response to antipsychotic medications." Neither Kraepelin, who called it dementia praecox, nor Bleuler, who renamed it schizophrenia, regarded delusions and hallucinations as the central characteristics of the illness. Layered over all of it is anosognosia — the illness often brings a lack of insight, which a first-episode review links to non-adherence and a poorer course of illness, and judgment is often impaired, which is why insight cannot be assumed and why so many nursing decisions on this page are about trust rather than persuasion.

02 The dopamine hypothesis is four pathways, and the side effects are not accidents

The link between dopamine and schizophrenia came from an accident: "the accidental discovery of dopamine D2 receptor blockers’ effectiveness in alleviating psychotic symptoms." Four dopamine pathways have been identified, and each one explains a different part of what a nurse sees. Mesolimbic — excessive dopamine activity here "is thought to contribute to the positive symptoms." Mesocortical — reduced dopamine "may underlie negative symptoms and cognitive deficits." Nigrostriatal — linked to the extrapyramidal motor side effects caused by D2 blockers. Tuberoinfundibular — responsible for the hyperprolactinemia seen with D2 blockade.

Read those four together and the whole drug problem falls out. A medicine that blocks D2 receptors everywhere corrects the mesolimbic excess and simultaneously creates deficits in the nigrostriatal and tuberoinfundibular pathways. The movement disorders and the galactorrhea are not unlucky side effects of an otherwise clean drug; they are the same pharmacology arriving in circuits that did not need it. And because "these observations suggest distinct pathophysiological mechanisms for schizophrenia’s positive and negative symptoms," one drug cannot be expected to treat both.

Aberrant salience is the modern refinement, and it explains what a delusion feels like from the inside. Mesostriatal dopamine neurons normally fire to reward prediction error — the mismatch between what was anticipated and what happened — and this firing assigns salience, the sense that something matters. In schizophrenia the firing is dysregulated, producing "a decoupling of dopamine signaling from genuinely salient stimuli, resulting in the misattribution of importance to irrelevant objects or events." A number plate, a song, a glance across a room arrives stamped as urgently significant. The delusion is the explanation the person builds for an experience of meaning they genuinely had. Two sourced limits keep this honest: there is a 2-to-4-week delay between peak D2 blockade and clinical response, which suggests secondary mechanisms do the real work, and "no present model of the pathophysiology of schizophrenia can comprehensively explain all the changes observed."

Four dopamine pathways, one drug. Blocking D2 receptors corrects the mesolimbic excess that drives positive symptoms and simultaneously produces the nigrostriatal movement disorders and the tuberoinfundibular prolactin rise — while doing little for the mesocortical deficit behind negative and cognitive symptoms.

03 A disorder of early brain development that waits until the twenties to appear

Genetics dominate the risk without determining the outcome. Twin and family studies indicate that genetic factors explain approximately 80% of the risk, yet the concordance rate in monozygotic twins is about 60% — which is the same data proving how much environment contributes. No single gene is responsible: genome-wide studies identified 130 risk genes "predominantly associated with neural differentiation, organization, and transmission," most of them outside coding regions and acting through gene-expression modulation. Schizophrenia is polygenic, with each gene contributing modestly. The one rare high-penetrance exception is the chromosome 22q11.2 deletion, which increases lifetime risk 25-fold. And the corollary that patients and families ask about directly: “genetic testing cannot predict who will develop schizophrenia.” An 80% heritability across 130 low-effect genes is a population statement, not a personal forecast.

Nearly 30% of those risk genes converge on the glutamate synapse. They affect "the functioning of the presynaptic and postsynaptic elements of the glutamatergic synapse by impacting N-methyl-D-aspartic acid (NMDA) receptor transmission," and multiple studies have found decreased NMDA glutamate receptor function. Dopamine, glutamate and GABA together modulate excitatory and inhibitory interneurons within cortical microcircuits, and postmortem work shows those microcircuits are altered in structure and function. The structural findings are measurable: lateral ventricle enlargement of about 25%, an approximate 2% reduction in overall brain volume concentrated in grey matter of the frontal and temporal lobes and the hippocampus, and reduced dorsolateral prefrontal cortex activity both at rest and during executive tasks.

The neurodevelopmental hypothesis explains the timing paradox. A mix of genetic risk and environmental exposure "during early brain development leads to the disorder," and these influences are "particularly significant in the prenatal and early life stages," setting the stage for symptoms that emerge in early adulthood. The patient-level version says the same thing: differences in brain connections and circuits "may begin developing before birth," and "changes to the brain that occur during puberty may trigger psychotic episodes in people who are already vulnerable." This is why the peak incidence sits in the early twenties for men and later in the twenties for women, and why new-onset schizophrenia after age 45 is uncommon enough that it should make you look for a medical cause instead.

The neurodevelopmental chain: genetic loading plus early environmental hits alter brain development decades before symptoms, with pubertal change and cannabis acting as triggers on an already vulnerable system.

04 What the criteria actually require — and the duration ladder that sorts the spectrum

The DSM-5-TR criteria, as relayed by both the medical and the nursing carrier, are specific about arithmetic. two or more core symptoms, each present for a significant part of a 1-month period — and at least one of them must be delusions, hallucinations, or disorganized speech. The other two candidates are grossly disorganized or catatonic behavior, and negative symptoms. Significant functional decline in work or relationships must be observed. Then the second number: continuous signs for at least 6 months, at least 1 month of which is active-phase symptoms. Symptoms within those six months may be prodromal or residual, including attenuated active-phase symptoms.

Teach the pair as one sentence: one month of active symptoms inside a six-month continuous course. That arithmetic is what sorts the whole spectrum. Brief psychotic disorder lasts from 1 day to under 1 month. Schizophreniform disorder covers psychotic symptoms lasting under 6 months. Schizophrenia needs the full six. Schizoaffective disorder combines a major mood episode with active schizophrenia symptoms, and the mood symptoms are present for most of the illness. Delusional disorder is distinguished by the absence of the other characteristic schizophrenia symptoms, such as prominent hallucinations or disorganized speech.

The exclusions matter as much as the inclusions. A mood disorder with psychotic features (schizoaffective, depressive or bipolar) has to be ruled out, as do drugs, medicines and medical illness as the cause; and in a person with a developmental disorder, the diagnosis also needs a month or more of prominent delusions or hallucinations. Two clinical consequences follow. First, the prodrome commonly presents with negative symptoms, which "can commonly be confused with those of depressive disorders" — schizophrenia "can easily be confused with depression in its initial stages." Second, the ordering rule is absolute: "it is only when clinicians have officially ruled out a substance, medication-induced, or other underlying medical cause that one can consider a primary psychotic disorder."

The duration ladder. The same symptom set becomes four different diagnoses depending on how long it runs, and every one of them is a diagnosis of exclusion until substance, medication and medical causes have been ruled out.

Causes & risk factors

Modifiable factors are teaching targets — the patient can act on them.

Genetic loading — twin and family studies attribute about 80% of risk, though monozygotic concordance is only about 60%; the disorder is polygenic across roughly 130 genes Chromosome 22q11.2 deletion — the one named rare variant, increasing lifetime risk 25-fold A first-degree family history of a primary psychotic disorder — a significant association, and one of the five discriminators from medical or neurologic psychosis Cannabis — a risk factor for schizophrenia, dose-dependent and more pronounced with earlier first use or more potent strains; heavy users were at 6 times greater risk than non-users in one study, and it worsens symptoms and causes more relapses and hospitalizations modifiable Other substance use — substance use disorders are more common in schizophrenia, and using them increases the chance symptoms return modifiable Prenatal and perinatal exposures — birth complications, season of birth, severe maternal malnutrition, and maternal influenza during pregnancy Childhood trauma and adverse childhood experiences, and early-life adversity modifiable Social isolation, urbanization and urban upbringing, migration, and minority ethnicity — a higher rate is linked to urban living and migrant status modifiable Male sex — incidence rate ratio approximately 1.7 (95% CI 1.46–1.97), with earlier onset, poorer premorbid functioning, more pronounced negative symptoms and more alcohol and substance use Age — peak incidence in the early twenties in men and later twenties in women, with new diagnoses becoming more common in women after the mid-forties Childhood onset before age 13 — rare, and "typically represents a more severe form of the illness with a poor response to antipsychotic medication" Medication nonadherence — the leading sourced cause of relapse, and each relapse "can increase residual dysfunction and deterioration" modifiable

Signs & symptoms

Each finding tied to the mechanism that produces it — and the triage it calls for.

Auditory hallucinations — voices commenting on the patient’s actions or conversing with each other early Expected
Why: Hallucinations are "perceived experiences in the absence of an external stimulus" and are "not under voluntary control." Auditory hallucinations are the most common in schizophrenia spectrum disorders, usually experienced as voices outside the head. The modality is diagnostically loaded: visual and tactile hallucinations predominate in severe alcohol withdrawal, and visual hallucinations are a hallmark of Lewy body dementia.
Command hallucinations — a voice telling the patient to do something Report immediately
Why: The emergency subtype. Assess with the sourced wording: "Are you hearing a voice that is telling you to do something?" followed by "Do you believe what you hear is real?" — if the answer is yes, the client is at increased risk for acting on the command. Patients with command hallucinations require close monitoring for suicide, homicide and other violence risk.
Delusions — most often persecutory, referential, grandiose or religious Hold & notify
Why: Fixed, false beliefs the person lacks insight into "even in the face of evidence that proves contrary to their validity." Persecutory is the most common. The version a nurse meets is concrete: a patient with persecutory delusions may believe the nursing staff is trying to poison them when they administer medications. Bizarre delusions are outside the realm of possibility; non-bizarre ones are possible but extraordinarily unlikely.
Thought broadcasting, insertion or withdrawal Hold & notify
Why: The first-rank cluster — the experience that one’s thoughts are being transmitted to others, placed into one’s mind, or removed from it. Under ICD-10 these qualify on their own as a single criterion for one month, which is how much diagnostic weight they carry.
Disorganized speech — tangential, circumstantial, loosened associations, neologisms, or incoherent word salad Expected
Why: Speech is the window onto thought form. Loosened associations are "sequences of unrelated or loosely related ideas"; circumstantial thought cannot give a direct answer "without excessive or unnecessary detail"; tangential thought "continually drifts from the topic of conversation, never to return to the original point"; neologisms are invented words without meaning. Thought blocking is the patient suddenly stopping speaking mid-sentence. In a patient already diagnosed this is an expected finding to document and track, not one to escalate on its own.
Flat, blunted or inappropriate affect, sometimes incongruent with the stated mood Expected
Why: Affect "may be incongruent with the reported mood, such as laughing when discussing sad events." Flat affect is a negative symptom — reduced expression of emotion through facial expression or voice tone — and is one of the findings that responds least to antipsychotic medication.
Disheveled appearance and collapsed self-care Expected
Why: Patients often present "with disheveled or unusual attire, reflecting a lack of self-care." This is avolition made visible, not a character judgment, and it is a nursing target: hygiene tasks are broken into smaller steps with visual cues and reinforced with praise, rather than being treated as refusal.
Catatonic behavior — stupor, mutism, odd gestures, posturing, waxy flexibility, or an excited state of aimless motor activity Hold & notify
Why: Catatonia is "a notable decrease in reactivity to the external environment," ranging from psychomotor retardation, immobility and severe rigidity with no verbal response, to an excitatory state of unrestricted motor activity. The nursing consequence is medical: "clients who are experiencing catatonia require assistance with nutrition, as well as other activities of daily living." Catatonia is now understood as a syndrome with many causes rather than a schizophrenia subtype, and mood disorders account for more cases of it than schizophrenia does.
The prodrome — falling grades or work performance, new trouble concentrating, suspiciousness, social withdrawal, declining hygiene, and difficulty telling reality from fantasy early Hold & notify
Why: "Gradual changes in thinking, mood, and social functioning often begin before the first episode of psychosis, usually starting in mid-adolescence," well before the first frank psychotic episode. This is the list to teach families, because early treatment of psychosis increases the chance of a successful remission and delays are linked to poorer outcomes.
Suicidal ideation, a plan, or access to means Report immediately
Why: Assessed at every contact. Suicide is the most common cause of premature death in schizophrenia, lifetime risk is 5% to 10%, and two-thirds of patients report at least one episode of suicidal ideation. Two amplifiers are specific to this disorder rather than to depression: command hallucinations and akathisia, whose severity is linked to suicidal ideation, aggression and violence.
Acute dystonia — forced upward gaze, neck twisting, jaw clenching or arched back, usually within 48 hours of a dose Report immediately
Why: Acute dystonia occurs within 48 hours of drug exposure in 50% of cases and within 5 days in 90%, as involuntary muscle contractions producing abnormal posturing: oculogyric crisis, torticollis, trismus, opisthotonus. The priority is the airway — evaluate for acute laryngeal dystonia, "which can result in life-threatening airway obstruction with difficulty breathing, swallowing, and speaking," and which may require intubation. Young men are more likely to have dystonic reactions.
Akathisia — an inability to remain still, with pacing, rocking, leg swinging or persistent fidgeting Hold & notify
Why: An intense inner restlessness usually involving the lower extremities and producing a compulsion to move, appearing days to weeks after starting or increasing a dose — the onset is “typically within 4 weeks of starting or increasing the medication dosage.” It is dangerous because it is misread: akathisia "is often misdiagnosed as anxiety, restless leg syndrome, or agitation," and the clinician may then increase the antipsychotic, further exacerbating it. Its severity is linked to suicidal ideation, aggression and violence.
Antipsychotic-induced parkinsonism — masked facies, stooped posture, slow shuffling gait, tremor, rigidity, bradykinesia Hold & notify
Why: Nigrostriatal D2 blockade reproducing the motor picture of Parkinson disease, with gait imbalance and difficulty rising from a chair. Older women are more susceptible. One trap is worth knowing: up to a third of medication-naive patients with new-onset schizophrenia may already show parkinsonian signs, so a movement finding at first presentation is not automatically a drug effect.
Tardive dyskinesia — grimacing, lip-smacking, tongue protrusions and excessive blinking late Hold & notify
Why: The tardive syndromes — tardive dyskinesia, tardive dystonia and tardive akathisia — "can develop after PROLONGED EXPOSURE to antipsychotic medications and are characterized by INVOLUNTARY MOVEMENTS IN THE LOWER FACE, LIMBS, AND TRUNK," and those movements "MAY BECOME PERMANENT EVEN AFTER DISCONTINUING THE MEDICATION." They emerge months or years after starting, not days. Chronic blockade causes compensatory upregulation of postsynaptic D2 receptors — dopamine supersensitivity — which is why movements can paradoxically worsen when the antipsychotic is reduced. Respiratory dyskinesias may appear as irregular breathing, grunting or involuntary vocalizations.
Neuroleptic malignant syndrome — fever, severe muscle rigidity, altered mental status and autonomic instability Report immediately
Why: A life-threatening reaction to a dopamine-receptor antagonist or to rapid withdrawal of a dopaminergic drug, developing over 24 to 72 hours and driven by a sudden fall in central dopaminergic activity. The DSM-5 major criteria, as relayed by StatPearls, are all three of exposure to a dopamine-blocking agent, severe muscle rigidity, and fever; at least two other criteria are needed from diaphoresis, dysphagia, tremor, incontinence, altered consciousness, mutism, tachycardia, labile blood pressure, leukocytosis and elevated creatine kinase. The main risk factor is starting or increasing the dose, and prior NMS carries up to a 40% recurrence rate.
Galactorrhea, breast enlargement, sexual dysfunction or menstrual irregularity Hold & notify
Why: The tuberoinfundibular pathway made clinical: D2 antagonism in the anterior pituitary disrupts the hypothalamic-pituitary-gonadal axis. Risperidone, paliperidone, amisulpride and high-potency first-generation agents have the greatest propensity. The escalation rule is specific: headache and vision changes together with a prolactin level 4 times the upper limit of normal warrant assessment for a pituitary tumor. Long term, prolactin-elevating agents are associated with reduced bone mineral density and more hip fractures.

Diagnostics

Test In this disorder Normal
There is no diagnostic test Collateral information from family members or close contacts is essential — a patient with impaired insight cannot be the only historian. Every test below exists to exclude something else, not to confirm schizophrenia "No laboratory, psychometric, or radiologic studies currently exist for diagnosing schizophrenia." The diagnosis is made after "a detailed psychiatric history and mental status examination and after ruling out other psychiatric and medical causes of psychosis" StatPearls; MedlinePlus (NLM) —
Initial evaluation laboratory panel Organic causes to review include syphilis, HIV/AIDS, brain lesions, heavy-metal toxicity, delirium, metabolic and endocrine disorders and the dementias — which is why the work-up comes before the label Work-up to exclude secondary causes of psychosis: urine toxicology screen, CBC and metabolic panel, urinalysis, TSH, liver function tests, vitamin B12 and HIV, with CT or MRI, EEG and lumbar puncture when indicated StatPearls (Schizophrenia; Psychosis) —
Urine toxicology — and the gap in it The sequencing rule is absolute: "it is only when clinicians have officially ruled out a substance, medication-induced, or other underlying medical cause that one can consider a primary psychotic disorder." A negative screen does not close the question when the history suggests a novel agent Screens for substances that cause psychotic symptoms. But "some substances which correlate to psychotic episodes — bath salts, certain synthetic strains of cannabis, psychedelics — may not show up on basic drug screen panels" —
ECG before specific agents Antipsychotics can cause "dangerous QT prolongation" — relevant in any patient with cardiac risk factors or other QTc-prolonging drugs Consider when QTc risk is present — antipsychotics can prolong the QT interval StatPearls (Psychosis) —
Primary psychosis versus medical or neurologic psychosis — five discriminators "The older the patient, the higher the risk for medical or neurological psychosis, especially in the hospital setting." In older adults the bedside rule is stronger still: visual hallucinations or illogical, disorganized thinking "can be considered signs of delirium unless proven otherwise, as primary psychotic disorders are rare to develop at an older age." Age of onset — primary presents late teens to early thirties, medical/neurologic often after 40 · Pattern — primary is subtle with a prodrome, medical/neurologic is acute · Genetics — family history associates with primary · Context — primary appears during life stressors, medical/neurologic in healthcare settings · Modality — primary is "generally synonymous with auditory hallucinations," medical/neurologic correlates with all other types except auditory —
Attention testing at the bedside Delirious patients also have difficulty maintaining consciousness, which fluctuates throughout the day. In schizophrenia the deficit is in insight and judgment with a clear sensorium. The first priority in any altered mental status is "ruling out any life-threatening conditions, eg, hypoxia, ST elevation in case of a myocardial infarction, or hypoglycemia" Ask the patient to recite the months of the year or the days of the week in reverse order — inattention is a common feature of delirium —
Quantitative symptom rating scales These are severity and progress instruments for tracking symptoms and function, not diagnostic tests PANSS — 30 items across positive (7), negative (7) and general psychopathology (16) subscales, each rated 1 (absent) to 7 (extreme); a PANSS-6 short form correlates well with the full version. BPRS — 18 items for tracking change over time. WHODAS — health and disability across life domains —
AIMS — the movement-disorder screen and its interval This is a nursing responsibility, not a formality — tardive movements "may become permanent even after discontinuing the medication," so how early they are caught is the only variable the team controls Baseline screening before starting, then routine follow-up screening with a validated scale — the AIMS, the Extrapyramidal Symptoms Rating Scale or the Barnes Akathisia Rating Scale — plus prompt reassessment whenever a new or worsening movement appears StatPearls (Extrapyramidal Side Effects) —
Laboratory picture in neuroleptic malignant syndrome No fetched source gives a numeric temperature or creatine kinase cut-off, and none should be taught. The CK "can be profound and typically correlates with disease severity." NMS is a clinical diagnosis — teach the pattern of fever with severe rigidity, altered mental status and autonomic instability, supported by rising CK, myoglobinuria and leukocytosis Metabolic panel with electrolytes and creatinine, creatine kinase, urinalysis for myoglobinuria, and a blood gas for metabolic acidosis. Findings are "consistent with rhabdomyolysis with an elevated CK and acutely declining renal function," and leukocytosis is common, from 10,000 to 40,000/mm³ with a left shift —

Complications

Warning: Suicide Report immediately
Lifetime risk of death by suicide is 5% to 10%, and suicide is the most common cause of premature death in schizophrenia. Two-thirds of patients report at least one episode of suicidal ideation.
Two risk amplifiers belong to this disorder specifically rather than to depression: command hallucinations, where believing the voice is real raises the risk of acting on it, and akathisia, whose severity is linked to suicidal ideation, aggression and violence. Clozapine carries an FDA indication for "Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder" — which is a reason to push toward it rather than around it. The generic assessment sequence and safety planning are owned by the Depression page; what this page adds is the two disorder-specific amplifiers.
Warning: Neuroleptic malignant syndrome Report immediately
Rare and lethal. Incidence is reported at 0.02% to 0.04% in schizophrenia specifically, with a 5% mortality rate; early reports exceeded 30% mortality, now reduced to under 10% with earlier detection and better supportive care.
Discontinuing the offending agent is paramount, followed by aggressive cooling, volume and electrolyte correction, and ICU-level monitoring — patients are prone to cardiac dysrhythmias and respiratory failure from chest-wall rigidity. Bromocriptine and dantrolene are the pharmacologic rescues in severe cases, with benzodiazepines for agitation and ECT if refractory. With early recognition most patients fully recover in 2 to 14 days. Re-initiation waits at least two weeks after resolution, uses lower-potency agents at low doses, avoids lithium alongside the neuroleptic, and teaches the patient to avoid dehydration.
Warning: Tardive dyskinesia Hold & notify
Risk accumulates with exposure rather than arriving at a threshold, which is why the monitoring is periodic and lifelong rather than a one-off check. What is sourced with numbers is the comparison between generations: a meta-analysis found tardive syndromes "in 30% of individuals treated with first-generation antipsychotic medications and 21% of individuals treated with second-generation antipsychotic medications." Older patients are also specifically named as more susceptible to medication-induced parkinsonism and tardive dyskinesia, while young men are more likely to have dystonic reactions.
Risk factors are cumulative drug exposure, advanced age, female sex, affective disorders, diabetes mellitus and a prior history of extrapyramidal symptoms — though it can develop even with short-term exposure. It is neither reliably permanent nor reliably reversible, which is the whole reason the monitoring schedule exists: the movements "may become permanent even after discontinuing the medication," yet stopping or changing the drug early still offers the best chance of recovery; VMAT2 inhibitors (valbenazine, deutetrabenazine) are "the first medications approved by the Food and Drug Administration to treat tardive syndromes." Early recognition is what changes the outcome, which is why baseline and routine follow-up screening matters.
Warning: Relapse — the commonest and most preventable complication Hold & notify
"Relapses typically occur when people stop taking their prescribed antipsychotic medication or when they take it sporadically." Some stop because they feel better. Each relapse "can increase residual dysfunction and deterioration and can contribute to despair, hopelessness, and suicide risk."
The heralding cues are specific and teachable: reduced sleep, social withdrawal, and worsening concentration. Recognising them early and intensifying treatment "are needed to minimize the disruption of the client’s life." Extrapyramidal symptoms are themselves a driver — they are "associated with poor compliance with antipsychotic medications, which may lead to relapse and increased morbidity" — so treating a movement disorder is relapse prevention. Long-acting injectables exist precisely for this problem, and cannabis use "causes more relapses and hospitalizations."
Caution: Premature death from physical illness
Life expectancy is shortened by an estimated 13 to 15 years. The drivers named are poor diet, weight gain, smoking and concurrent substance use, compounded by an inactive lifestyle and medication side effects.
Second-generation agents cause significant weight gain and hypertension and elevate lipid and glucose levels, raising the risk of diabetes and cardiovascular disease — olanzapine and clozapine carry the most significant metabolic risk. More than half of patients have multiple comorbidities. This is why routine metabolic parameters are a nursing responsibility rather than a primary-care afterthought, and why smoking cessation and physical-health follow-up sit inside psychiatric care.

Medications for this condition

Why each class is prescribed here — every card links to its full pharmacology page.

Antipsychotics First-line
Nervous · haloperidol

The gold-standard treatment, with a precisely limited target. Antipsychotic medications "are typically used to treat psychosis." What they fix and what they do not is the sentence that organises the whole page: they are "most effective in positive symptoms of psychosis — hallucinations, delusions, disorganized thoughts and behavior — and less useful for negative symptoms," with "little evidence that antipsychotics substantially improve negative or cognitive symptoms" except where those are secondary to positive symptoms. Efficacy arrives when central concentrations occupy around 70% of dopamine D2 receptors — clozapine and quetiapine are the exceptions, working at lower occupancy. Teach the timeline (NIMH): "Some symptoms, such as agitation and hallucinations, typically go away within days of starting antipsychotic medication. Other symptoms, such as delusions, usually go away within a few weeks. However, people may not experience the full effects of antipsychotic medication for up to 6 weeks." On generations, resist the shortcut: second-generation agents cause fewer extrapyramidal and tardive effects while most carry a higher risk of metabolic syndrome. Beyond that trade-off, the second-generation drugs are not a homogeneous class: in a large meta-analysis only four of the nine compared (amisulpride, clozapine, olanzapine, risperidone) beat first-generation drugs on overall efficacy, and only by small-to-medium margins, while a later network meta-analysis in adults with multi-episode schizophrenia found efficacy differences between individual drugs mostly gradual and side-effect differences more marked — so the choice is made drug by drug, weighing the outcomes that matter most, the patient’s medical problems and preferences. Start low: young people in a first episode of psychosis seem to respond to low doses and are more susceptible to extrapyramidal effects and acute weight gain (first-episode review); older adults need lower doses, and in general, start at the lowest dose and titrate up slowly to reduce side effects, then give a typically effective dose for at least 4–6 weeks before judging it ineffective (WHO). Dose deliberately: the dose-response curve plateaus — doses above the approved range do not yield greater efficacy, only more adverse effects. Long-acting injectables address nonadherence. Clozapine is the answer for the roughly one-third with treatment-resistant schizophrenia — symptoms persisting despite two or more adequate trials with documented adherence — with about 40% responding — and its FDA indications are exactly those two groups: "severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment" and "Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior." Despite that evidence, clozapine is widely underused and often started years late; the main barriers are the mandatory blood testing, fear of serious side effects, doubts about adherence, difficulty identifying suitable patients, fragmented services, and too little training. It requires absolute neutrophil count monitoring through the US Clozapine REMS program because of agranulocytosis risk — the schedule and the cut-offs belong to the class page. Clozapine’s other disorder-side burdens: seizure with high doses or rapid escalation, myocarditis, gastrointestinal hypomotility with constipation, fecal impaction, ileus and death requiring a prophylactic bowel regimen, and sialorrhea in 90% of patients, which must be managed to prevent discomfort, stigma and aspiration pneumonia. Never stop abruptly — abrupt withdrawal causes dizziness, nausea and vomiting, and uncontrolled movements of the mouth, tongue or jaw.
Anticholinergics (Atropine)
Autonomic · atropine

A narrow, two-condition role — and the boundaries matter more than the indications. Anticholinergics treat acute dystonia and antipsychotic-induced parkinsonism. For an acute dystonic reaction, an intramuscular injection of 1 to 2 mg of benztropine provides rapid relief, with further injections if needed, and parenteral diphenhydramine or benztropine resolves the symptoms dramatically within 10 to 30 minutes — a clock the nurse should be watching. For parkinsonism, management is dose reduction, changing agents, or amantadine or an anticholinergic such as benztropine. Three sourced boundaries are as examinable as the indications. First, anticholinergics are not recommended for tardive dyskinesia, akathisia, or neuroleptic malignant syndrome. Second, in tardive dyskinesia they should be discontinued, because they may worsen it. Third, akathisia "does not generally respond to anticholinergic agents" — which is itself evidence that akathisia has a different mechanism. Prophylaxis is not routine: current guidelines generally do not recommend prophylactic or long-term anticholinergics in patients on antipsychotics, because the peripheral burden (dry mouth, urinary disturbance, constipation) and the central harm (cognitive dysfunction and delirium) land on a population already cognitively impaired, and may worsen that impairment and quality of life. The single sourced exception is narrow: benztropine may be used for the first week of a new antipsychotic and then tapered slowly to prevent an acute dystonic reaction. Remember also that the antipsychotic itself has anticholinergic effects — urinary retention, blurred vision, tachycardia, constipation and cognitive difficulty, especially in older patients — so the two burdens compound, and decreasing the antipsychotic dose is the first-choice strategy for those symptoms.
Benzodiazepines
Nervous · diazepam

Three sourced disorder-side roles, all adjunctive and all short. Acute agitation: for "an agitated, potentially aggressive, acutely psychotic patient at risk of harming themselves or someone else," who should be hospitalized, "an injectable form of a typical antipsychotic with a benzodiazepine is most effective in this case." Short-term sedatives may also be considered for agitation or insomnia during a psychotic episode. Catatonia: benzodiazepines "have evidence as an effective treatment for catatonic symptoms of psychosis," and malignant catatonia specifically "shows robust responsiveness — reports reveal a full recovery in up to 80% of patients — with rapid initiation of benzodiazepines and electroconvulsive therapy." This is a genuinely high-stakes use: catatonia is "potentially fatal if untreated," and delayed diagnosis risks malnutrition, infection and death. NMS agitation: benzodiazepines "may be useful in controlling agitation" alongside stopping the offending agent and supportive care. A fourth, weaker role is akathisia, where benzodiazepines "have historically been used" although the supporting data are limited. The framing to teach: a benzodiazepine here calms the patient so the antipsychotic can work, or rescues a catatonic state — it never treats the psychosis itself.

Beyond medications

  • The psychosocial interventions are not optional extras — they treat what the drugs do not. They include psychosocial treatments, family education and support, coordinated specialty care, and assertive community treatment, with CBT, skills training, supported employment and cognitive remediation for the symptoms medication leaves behind. Patients "who participate in regular psychosocial treatments are less likely to relapse or be hospitalized," and CBT, skills training, supported employment and cognitive remediation "can help address the negative and cognitive symptoms" that medication largely does not.
  • Coordinated specialty care (CSC) is the first-episode standard, and it beats usual care on measured outcomes. A team delivers "psychotherapy, medication management, case management, employment and education support, and family education and support," and "compared to typical care for early psychosis, CSC is more effective at reducing symptoms, improving quality of life, and increasing involvement in work or school." The goal is to link the person with a CSC team as soon as possible after psychotic symptoms begin. Named US programs include NAVIGATE, OnTrackNY, STEP, EASA, the Connection Program, CCS and CSP, with Supported Employment and Education an important component.
  • Time to treatment is itself an intervention. "Early treatment of psychosis increases the chance of a successful remission," treatments "work better when they are delivered closer to the time when psychotic symptoms first appear," and "the longer the symptoms go untreated, the greater the risk for developing additional problems — abusing substances, having legal trouble, or becoming homeless." Delays in treatment have statistical links with poorer outcomes.
  • Assertive community treatment (ACT) is designed for people "at risk for repeated hospitalizations or homelessness," using a multidisciplinary team with a shared caseload, direct service provision, high frequency of client contact, low client-to-staff ratios and outreach to clients in the community. ACT has been shown to reduce hospitalizations and homelessness — which matters against a backdrop of psychosis prevalence as high as 21% among homeless people living on the street.
  • Family education and support, because the family is doing most of the care. Psychosis "can take a heavy toll on a client’s family members, significant others, and friends," and educational programs covering symptoms, treatments and the course of recovery "lessen their distress, bolster their own coping strategies, and empower them to offer effective assistance." Formats include individual sessions, multi-family workshops and support groups.
  • Electroconvulsive therapy has a defined niche, not a general one: it "can be considered in treatment-resistant cases where its efficacy rates range from 40% to 70%." It is also an option for treatment-resistant NMS and for malignant catatonia, where rapid benzodiazepines and ECT produce full recovery in up to 80%.
  • When to hospitalize — the sourced decision rule. Hospitalization is indicated in the acute phase if the client is "a danger to self (eg, refuses to eat or is too disorganized to function in the community) or to others (eg, is behaving in a threatening manner)." Admission provides safety, structure and support. Because anosognosia may impair the client’s ability to recognize their mental illness, court-ordered hospitalization may be required, and involuntary admission criteria vary by state and country.
  • Plain-text pharmacology with no class page of its own. VMAT2 inhibitors — valbenazine, deutetrabenazine and tetrabenazine — are the first FDA-approved treatments for tardive syndromes; tetrabenazine (12.5 to 100 mg daily) reduces severity but needs monitoring for depression and parkinsonism. Switching to quetiapine or clozapine, which carry lower tardive risk, is also sourced. For akathisia: a beta-blocker such as propranolol, or mirtazapine 7.5 to 15 mg once daily, which "has been found to be as effective as beta-blockers and may be considered first-line therapy" — with the caution that high doses of mirtazapine may worsen akathisia and beta-blockers risk bradycardia and hypotension. For NMS: bromocriptine and dantrolene. For parkinsonism: amantadine. For refractory tardive dystonia: botulinum toxin, baclofen, deep brain stimulation and pallidotomy.
  • Managing the metabolic burden is disorder-side work. Initial management is lifestyle change and structured behavioral programs; switching to an antipsychotic with lower metabolic risk can also help; and symptomatic treatment includes statins, antihypertensives and metformin for weight loss. Two cautions are specific and sourced: newer weight-loss drugs "have not been tested explicitly for antipsychotic-induced weight gain and may exacerbate gastric hypomotility," and stimulant weight-loss medications are not advised because of the risk of exacerbating psychosis.

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Assessment & monitoring
Ask about hallucination content without conceding the voices are real: ask "What do you hear?" — never "What are the voices saying?"
Why: The sourced wording rule is explicit: "do not imply the perceptions are real." Then assess when they began, their content, whether they are supportive or distressing, background or intrusive, what makes them worse or better, how the client responds and what they do to cope. Behavioural cues that a patient is hallucinating right now include eyes tracking an unheard speaker, muttering to oneself, appearing distracted, suddenly stopping a conversation as if interrupted, or intently watching a vacant area of the room.
Screen every patient for command hallucinations with the two-question sequence, and escalate immediately if the answer to the second is yes.
Why: Ask "Are you hearing a voice that is telling you to do something?" then "Do you believe what you hear is real?" — "if the answer is 'Yes,' the client is at increased risk for acting on the command." These patients require close monitoring for suicide, homicide and other violence risk.
Screen for abnormal movements at baseline and routinely during treatment with a validated scale, and reassess promptly when a new movement appears.
Why: Tardive movements "may become permanent even after discontinuing the medication," so the value of screening is entirely in how early it catches them.
Record the metabolic parameter set at baseline — personal and family history of diabetes and dyslipidemia, weight and height, blood pressure, fasting plasma glucose and fasting lipid profile — and repeat the weight, glucose and lipid checks at least annually.
Why: Second-generation antipsychotics raise weight, lipids and glucose, so "Weight, glucose levels, and lipid levels should be monitored before treatment is initiated then annually." The stakes are the 13-to-15-year mortality gap, not a checkbox.
Assess gait and orthostatic blood pressure as a fall risk, and reassess after every dose change.
Why: Fall risk "may be increased due to orthostatic hypotension, impaired balance, bradykinesia, or other movement disorders." Orthostasis comes from alpha-receptor blockade, especially with clozapine and quetiapine; bradykinesia comes from nigrostriatal blockade. Teach slow position changes from lying to sitting to standing, handrails, and asking for help when unsteady.
In an older adult with new psychotic symptoms, assume delirium until proven otherwise and test attention at the bedside.
Why: "Primary psychotic disorders are rare to develop at an older age," visual hallucinations and disorganized thinking in this group "can be considered signs of delirium unless proven otherwise." Delirium is missed often enough in hospital that the bedside screen has to be deliberate. Ask for the months of the year or days of the week in reverse; inattention and a fluctuating level of consciousness point to delirium, not schizophrenia.
Interventions & safety
Do not question or argue with a delusion. Address the fear underneath it and offer what would make the patient feel safer.
Why: The sourced rule: "until the client’s ability to test reality improves, trying to prove the delusion is incorrect can intensify it and cause the client to view the staff as people who cannot be trusted." The worked example is a template — to "The doctor is here. He wants to kill me," the answer is "Yes, the doctor is here and wants to see you. They talk with all of the clients about their treatment. Would you feel more comfortable if I stayed with you during your meeting?" Assess whether the patient can reality-test and whether they believe there is danger.
For hallucinations, offer your own perception with empathy rather than agreement or contradiction, then redirect to reality-based activity in the here and now.
Why: The sourced phrasing is: "I don’t hear angry voices that you hear, but that must be very frightening for you." Avoid referring to hallucinations as if real, but do not try to convince the patient they are not — address the underlying emotion, need or theme the hallucination expresses.
With a paranoid patient, keep consistent staff assignments, never laugh or whisper where the patient can see but not hear, and ask permission before touching them — including before taking a blood pressure.
Why: These three are sourced interventions, not courtesies. Whispering within sight confirms the belief that something is being concealed; unannounced touch confirms that the patient has no control. Consistency of staff is the substrate trust is built on, and trust is what makes assessment possible.
Use short, simple, clear sentences, speak calmly and slowly, limit environmental stimuli, and allow extra time for responses.
Why: Each has its own rationale in the source: simple sentences because thought disorganization and cognitive deficits impair processing; a calm slow voice because it "reduces anxiety and helps de-escalate agitation"; low stimulation because clients "may be easily overwhelmed or distracted"; and extra time because thought blocking, slowed cognition or preoccupation with internal stimuli delay verbal responses. Use the patient’s name and keep a consistent routine, which "increase trust and reduce paranoia."
Manage violence risk with trust, supervision at unpredictable intervals, diversion, adherence support and relocation of targeted individuals — and treat seclusion or restraint as a last resort only.
Why: Sourced risk factors for aggression are interpersonal conflict, paranoia, delusions, impaired judgment, limited impulse control, fear, and disagreement with unit rules. The sources genuinely conflict on restraint and the conflict should be taught rather than averaged: the psychosis chapter states "physical restraints should be avoided at all costs and correlate with increased mortality," while the nursing text permits seclusion or restraint "when other alternatives have not been successful in keeping the client or others safe," under ANA guidance. Search belongings on admission and repeat whenever circumstances suggest a weapon.
Recognise an acute dystonic reaction as an airway assessment first, then give the ordered parenteral anticholinergic and watch the clock.
Why: Acute laryngeal dystonia "can result in life-threatening airway obstruction with difficulty breathing, swallowing, and speaking" and may require intubation and mechanical ventilation. Half of acute dystonias occur within 48 hours of exposure and 90% within 5 days. Parenteral diphenhydramine or benztropine resolves the symptoms dramatically within 10 to 30 minutes — if it does not, reassess rather than repeat blindly.
Treat suspected NMS as an ICU problem: stop the antipsychotic, cool aggressively, correct volume and electrolytes, and escalate.
Why: "Discontinuing the offending agent is paramount." Patients are prone to cardiac dysrhythmias and respiratory failure due to chest-wall rigidity and "should be admitted for close monitoring in an intensive care unit setting." Remember the mimics that must be excluded — CNS infection, heatstroke, agitated delirium, toxic encephalopathy, withdrawal syndromes, metabolic emergencies and nonconvulsive status epilepticus — because "acute encephalitis, meningitis, or brain abscess must be excluded in patients presenting with fever and mental status changes."
For a catatonic patient, assist with nutrition, hydration and all activities of daily living while the cause is investigated.
Why: Catatonia is "potentially fatal if untreated," and "delayed diagnosis increases the risk of complications such as malnutrition, infections, and even death." Its causes extend well beyond schizophrenia — mood disorders cause more cases, and the exclusion list includes nonconvulsive status epilepticus, autoimmune encephalitis, drug intoxication and withdrawal, stroke and traumatic brain injury.
Patient & family teaching
Teach the response timeline before the first dose: agitation and hallucinations often settle within days, delusions within a few weeks, full benefit takes 4 to 6 weeks or more.
Why: Agitation and hallucinations often ease within days, but the full effect can take up to 6 weeks. A patient who expects to feel well tomorrow concludes the medicine does not work and stops — and stopping or taking it sporadically is the leading sourced cause of relapse.
Never stop the medication suddenly, and report any involuntary or uncontrollable movement immediately.
Why: Abrupt withdrawal "can cause dizziness; nausea and vomiting; and uncontrolled movements of the mouth, tongue, or jaw," and "relapses typically occur when people stop taking their prescribed antipsychotic" medication. The sourced rule is that "medication should never be stopped suddenly. After talking with a prescriber, clients can gradually taper their medications in some situations" — and that most people with schizophrenia must stay on an antipsychotic continuously for months or years. New involuntary movements may be the first sign of a tardive syndrome, where early action changes the prognosis.
Teach the relapse warning triad by name: reduced sleep, social withdrawal and worsening concentration — and agree in advance who gets called.
Why: These are the sourced early cues. Recognising them and implementing intensive treatment early "are needed to minimize the disruption of the client’s life," and each relapse "can increase residual dysfunction and deterioration and can contribute to despair, hopelessness, and suicide risk."
Teach concrete self-management strategies for hallucinations rather than only "tell someone."
Why: The sourced techniques are specific and usable: use other sounds to compete with the voices — talking with people, music, television, reading aloud, singing, humming; check reality against others by asking trusted people whether they experience the same thing; tell the voices to go away out loud, or silently if others are nearby, and tell yourself they are a symptom and not real; slow the breathing by inhaling through the nose to a count of four, holding, then exhaling slowly; avoid overly loud or stressful places and overly critical people; and develop a written plan with the provider for how to cope.
Teach cannabis and alcohol avoidance as relapse prevention, with the number attached.
Why: Cannabis risk is dose-dependent and worse with earlier use and more potent strains, heavy users were at 6 times greater risk of a schizophrenia diagnosis in one study, and it "worsens symptoms of psychosis in genetically predisposed individuals and causes more relapses and hospitalizations." Patients should also avoid alcohol and other CNS depressants because their ability to drive or operate machinery may be impaired.
Give the family the early-warning list and the crisis instructions in writing, including 988.
Why: "Contacting the 988 Suicide and Crisis Lifeline if the patient feels like harming themselves or someone else should be STRONGLY ENCOURAGED." Give it in writing, before it is needed, to the people who will be in the room. Pair it with the sourced monitoring rule: clients with command hallucinations require close monitoring for suicide, homicide and other violence risk, and the family should know which changes bring that risk forward — reduced sleep, social withdrawal and worsening concentration.
Ask the cultural formulation questions before labelling a belief as delusional.
Why: "Some beliefs may be delusional in one setting but culturally sanctioned in another and not necessarily a manifestation of psychiatric illness." The sourced questions are "How do other people in your culture view experiences like hearing voices or seeing things?", "Do you have any cultural or spiritual beliefs that help explain what you’re going through?", and "Are there any traditional remedies, rituals, or religious practices you use to feel better?" — and the answers are used to individualize the plan of care.

How a real nurse thinks

The clinical-judgment loop, worked for a typical presentation — reasoning, not reference.

  1. 1
    Recognize cues

    The movement is the headline and the timing confirms it. Forced upward gaze is an oculogyric crisis, the neck twisting is torticollis, and the clenched jaw is trismus — three named presentations of acute dystonia, which occurs within 48 hours of drug exposure in 50% of cases and within 5 days in 90%. He is 36 hours from his first dose, squarely inside that window, and young men are more likely to have dystonic reactions. The tachycardia, hypertension and tachypnea are consistent with pain and fear rather than with a separate process. The second cue set is in the evening note: a command hallucination ("get out before they finish it") and a persecutory delusion about poisoned food that is already reducing his intake. And a third cue is what is absent — no fever, no rigidity beyond the dystonic muscles, and a clear sensorium, which matters for what comes next.

  2. 2
    Analyze cues

    Two questions have to be separated. First, is this dystonia or is it neuroleptic malignant syndrome? NMS requires all three major criteria — exposure to a dopamine-blocking agent, severe muscle rigidity, and fever — plus at least two others. He has the exposure and localized muscle contraction, but he is afebrile and the rigidity is confined to the dystonic groups, so the major criteria are not met. That does not make him safe; it makes him a different emergency. Second, and more urgent: is the airway involved? The sourced instruction is to evaluate for acute laryngeal dystonia, "which can result in life-threatening airway obstruction with difficulty breathing, swallowing, and speaking," which can require intubation. He is swallowing with effort and speaking in short phrases — findings that sit close enough to that description to be treated as a warning, even though phonation is intact and there is no stridor. Separately, the command hallucination and the food-related delusion are both active safety problems that the dystonia does not cancel.

  3. 3
    Prioritize

    Airway first. Everything else on this list waits behind the question of whether he can breathe and swallow. Second, the ordered parenteral anticholinergic, because acute dystonia is treatable in minutes and leaving a frightened patient in a painful forced posture is both cruel and a threat to his willingness to take the next dose. Third, stay with him and keep the environment low-stimulation — he is paranoid, in pain, and being approached by staff at night, which is the exact combination that escalates. Fourth, reassess the command hallucination, since he has not been asked about it since the evening shift and the belief he has to "get out" is now happening in a body he cannot control. Fifth, the nutrition problem created by the poisoning delusion, which is a day-shift issue unless intake falls further.

  4. 4
    Generate solutions

    Anticipate 1 to 2 mg of benztropine intramuscularly, which "provides rapid relief of an acute dystonic reaction," with additional injections if necessary and relief expected within 10 to 30 minutes of a parenteral anticholinergic. Anticipate a review of the antipsychotic — first-generation agents "appear to precipitate acute dystonia more frequently," and one sourced option is a short course of benztropine for the first week of a new antipsychotic, then tapered, specifically to prevent this. Anticipate that the team will not simply stop the antipsychotic, because his psychosis is untreated and a dystonic reaction is treatable. Plan the command-hallucination reassessment using the sourced wording — "Are you hearing a voice that is telling you to do something?" and "Do you believe what you hear is real?" — with increased supervision and rounds at unpredictable intervals if the answer to the second is yes. For the food delusion, the approach is not to argue: address the fear, not the belief, and offer what would make him feel safer, such as sealed packaged food he opens himself.

  5. 5
    Take action

    Stay with him, sit at eye level, speak slowly in short sentences, and tell him plainly that this is a known reaction to the medicine, that it is not permanent, and that the treatment works in minutes — a paranoid patient in a forced posture needs to be told what is happening to him before he is touched. Ask permission before touching him, including for the injection. Escalate with an SBAR: "24-year-old man, 36 hours after his first antipsychotic dose, with an oculogyric crisis, torticollis and trismus — an acute dystonic reaction. He is afebrile with no generalised rigidity, so this is not NMS. He is swallowing with effort and speaking in short phrases, so I am watching the airway. I am giving the ordered benztropine now, and I would like the antipsychotic plan reviewed. Separately, he reported a command hallucination on the evening shift and is eating 20% of meals because he believes the food is poisoned." Three traps to avoid. Calling this NMS and stopping all treatment — the major criteria are not met, and fever is one of them. Reassuring him that the voices are not real — do not try to convince him, offer your perception and address the fear. And treating the poor intake as non-compliance rather than as the delusion it is.

  6. 6
    Evaluate

    Success within 30 minutes: gaze and neck released, jaw relaxed, pain resolved, heart rate and blood pressure settling, swallowing comfortable. If the posture has not broken by then, that is a reason to reassess and to escalate again — not to assume the drug will eventually work. Over the next days: he keeps taking the antipsychotic, and the team decides whether a short tapered anticholinergic course or an agent change is the answer. Over the next weeks: teach that agitation and hallucinations often settle within days, delusions within a few weeks, and full benefit takes 4 to 6 weeks or more — and that this is why he should not stop. Reinforce never stopping abruptly, reporting any new involuntary movement, and avoiding cannabis, which raises relapse and hospitalisation risk. Record the AIMS at the 6-to-12-month interval against the baseline already on file. Refer him to a coordinated specialty care first-episode program, because early, coordinated treatment measurably improves symptoms, quality of life and return to work or school. Re-escalation triggers set in advance: fever with generalised rigidity means NMS, new restlessness he cannot sit through means akathisia rather than anxiety, and reduced sleep with social withdrawal and poorer concentration means relapse.

Scenario — you’re the nurse

Work each question before revealing the answer. Rationales explain the wrong options too.

Inpatient psychiatric unit, day 2 of admission · 0340

A 24-year-old man was admitted yesterday after six months of falling grades, social withdrawal, declining hygiene and new suspiciousness, with four weeks of hearing two voices discussing him and a belief that his food is being poisoned. He was started on an antipsychotic at a deliberately low first-episode dose 36 hours ago. The night nurse is called to his room because he is holding his neck and cannot look down.

0340 vitals — HR 118 · BP 142/88 · RR 22 · T 36.9 °C · SpO2 97% on room air
Observation — eyes forced upward and fixed, neck twisted to the right, jaw clenched; he is frightened, tearful and cannot lower his gaze voluntarily
Airway — speaking in short phrases, swallowing saliva with visible effort; no stridor, no drooling, phonation intact
Chart — first antipsychotic dose 36 hours ago · baseline AIMS recorded on admission · baseline weight, height, BP, fasting glucose and fasting lipids drawn · PRN benztropine 1 to 2 mg IM ordered for an acute dystonic reaction · CBC, chemistry with TSH, urine toxicology, RPR and HIV all unremarkable
Nursing note from evening shift — "States a voice told him to get out before they finish it. Denies plan. Ate 20% of dinner, states staff are poisoning the tray."
Q1 Select all that apply
Which findings require immediate follow-up? Select all that apply.
  1. A. Forced upward gaze with neck twisting and a clenched jaw, 36 hours after the first antipsychotic dose
  2. B. Swallowing saliva with visible effort and speaking only in short phrases
  3. C. A reported voice telling him to "get out before they finish it"
  4. D. Eating 20% of meals because he believes the food is poisoned
  5. E. Temperature 36.9 °C
Reveal answer & rationale
Answer: A, B, C, D
The forced gaze, torticollis and trismus (A) are an acute dystonic reaction, which occurs within 48 hours of exposure in 50% of cases — he is at 36 hours. The swallowing effort and short phrases (B) are the most urgent finding of all, because the sourced instruction is to evaluate for acute laryngeal dystonia, which "can result in life-threatening airway obstruction with difficulty breathing, swallowing, and speaking." The command hallucination (C) requires the two-question assessment and close monitoring for suicide, homicide and other violence risk. Poor intake driven by a persecutory delusion (D) is a nutrition problem the delusion is causing, and the sourced response is to address the fear rather than argue the belief. The normal temperature (E) is the finding that argues against NMS, since fever is one of its three required major criteria — it is reassuring, not actionable.
Q2 Multiple choice
The nurse understands that the correct first action for this presentation is:
  1. A. Hold all further antipsychotic doses permanently and notify the prescriber in the morning
  2. B. Assess the airway for laryngeal involvement, then give the ordered parenteral anticholinergic
  3. C. Obtain a creatine kinase level and start cooling measures for neuroleptic malignant syndrome
  4. D. Reassure the patient that the sensation is not real and reorient him
Reveal answer & rationale
Answer: B
Airway assessment followed by the parenteral anticholinergic (B) is correct: laryngeal dystonia can obstruct the airway and may require intubation, and benztropine 1 to 2 mg intramuscularly "provides rapid relief," with resolution expected within 10 to 30 minutes. Permanently stopping the antipsychotic (A) leaves an untreated first-episode psychosis for a reaction that is treatable in minutes, and waiting until morning abandons a frightened patient in a painful forced posture. Treating this as NMS (C) misreads the criteria — NMS requires all three of dopamine-blocker exposure, severe muscle rigidity and fever, and he is afebrile with contraction confined to the dystonic muscles. Reorienting him (D) confuses a real, physical, drug-induced muscle contraction with a hallucination; the posture is not a perception, and telling him it is not real would be both wrong and trust-destroying.
Q3 Put in order
Put the nurse’s actions in order:
  1. A. Administer the ordered parenteral anticholinergic
  2. B. Assess for laryngeal involvement — stridor, drooling, difficulty swallowing or speaking
  3. C. Reassess the command hallucination using the two-question sequence
  4. D. Notify the prescriber that the antipsychotic plan needs review
Reveal answer & rationale
Correct order: B → A → D → C
Airway comes first (B), because acute laryngeal dystonia "can result in life-threatening airway obstruction" and may require intubation — nothing else on this list matters if he cannot breathe. The anticholinergic follows immediately (A): relief is expected within 10 to 30 minutes, and delaying it prolongs a painful, frightening reaction that threatens his willingness to accept the next dose. Notifying the prescriber (D) comes next so the antipsychotic plan can be reviewed, including the sourced option of benztropine for the first week then tapered. Reassessing the command hallucination (C) is genuinely important and requires escalation if he believes the voice is real — but it is a conversation that needs him out of acute distress to be meaningful, so it follows rather than precedes the treatment.
Q4 Multiple choice
Three weeks later the patient is pacing the corridor constantly, rocking when seated and swinging his leg, and says he "cannot sit still inside." The nurse should recognize this as:
  1. A. Anxiety, which should be managed by increasing the antipsychotic dose
  2. B. Akathisia — which must not be treated by increasing the antipsychotic, and which carries a suicide and violence risk
  3. C. Early tardive dyskinesia, which should be treated with benztropine
  4. D. A return of positive symptoms, indicating treatment failure
Reveal answer & rationale
Answer: B
Akathisia (B) is "an inability to remain still — an intense sensation of unease or an inner restlessness that usually involves the lower extremities," with an onset “typically within 4 weeks of starting or increasing the medication dosage”, with pacing, rocking and shifting position as the objective signs. The reason it is the dangerous answer is the sourced trap in option A: akathisia "is often misdiagnosed as anxiety, restless leg syndrome, or agitation," and the clinician may then increase the antipsychotic, further exacerbating it — and "the severity of akathisia is linked to suicidal ideation, aggression, and violence." Calling it tardive dyskinesia (C) is wrong on both timing and treatment: tardive syndromes emerge months or years in, and anticholinergics are explicitly not recommended for akathisia or tardive dyskinesia and may worsen the latter. Treatment failure (D) misreads restlessness as psychosis; sourced options here are a beta-blocker such as propranolol or low-dose mirtazapine, which "may be considered first-line therapy."
Q5 Multiple choice
Which statement by the patient at discharge indicates correct understanding of his medication?
  1. A. "If I feel completely better in a couple of weeks, I can stop taking it."
  2. B. "It may take four to six weeks or more for the full benefit, and I should call my prescriber rather than stop it myself if anything worries me."
  3. C. "If I notice my mouth or tongue moving on its own, that is expected and will settle."
  4. D. "A little cannabis is safer than alcohol now that I am on this medicine."
Reveal answer & rationale
Answer: B
The full therapeutic effect "can span from 4 to 6 weeks or more," and the sourced rule is that "medication should never be stopped suddenly" — "after talking with a prescriber, clients can gradually taper their medications in some situations" (B). Stopping because he feels better (A) is the leading sourced cause of relapse — people stop because they feel better — and abrupt withdrawal also causes dizziness, nausea and vomiting, and uncontrolled movements of the mouth, tongue or jaw. Dismissing new oral movements (C) is the opposite of the teaching: clients are told to contact their provider if any involuntary or uncontrollable movements develop, because early recognition changes the tardive prognosis. Cannabis (D) is the single most strongly sourced modifiable relapse risk here — heavy users had 6 times greater risk of a schizophrenia diagnosis in one study, and it "causes more relapses and hospitalizations."

Common questions

What causes schizophrenia & psychotic disorders?
Common causes and risk factors include genetic loading — twin and family studies attribute about 80% of risk, though monozygotic concordance is only about 60%; the disorder is polygenic across roughly 130 genes, chromosome 22q11.2 deletion — the one named rare variant, increasing lifetime risk 25-fold, a first-degree family history of a primary psychotic disorder — a significant association, and one of the five discriminators from medical or neurologic psychosis, cannabis — a risk factor for schizophrenia, dose-dependent and more pronounced with earlier first use or more potent strains; heavy users were at 6 times greater risk than non-users in one study, and it worsens symptoms and causes more relapses and hospitalizations, other substance use — substance use disorders are more common in schizophrenia, and using them increases the chance symptoms return, and others.
What are the early signs of schizophrenia & psychotic disorders?
Early findings include Auditory hallucinations — voices commenting on the patient’s actions or conversing with each other, The prodrome — falling grades or work performance, new trouble concentrating, suspiciousness, social withdrawal, declining hygiene, and difficulty telling reality from fantasy.
Which findings should a nurse report immediately in schizophrenia & psychotic disorders?
Report immediately: Command hallucinations — a voice telling the patient to do something, Suicidal ideation, a plan, or access to means, Acute dystonia — forced upward gaze, neck twisting, jaw clenching or arched back, usually within 48 hours of a dose, Neuroleptic malignant syndrome — fever, severe muscle rigidity, altered mental status and autonomic instability, Suicide, and others. These signal deterioration that needs rapid intervention.
Why do antipsychotics help the voices but not the withdrawal and flat affect?
Because those two symptom groups come from opposite dopamine problems in different pathways. Positive symptoms are attributed to excessive dopamine activity in the mesolimbic pathway, which a D2 blocker corrects. Negative and cognitive symptoms are attributed to reduced dopamine in the mesocortical pathway — blocking D2 receptors there cannot restore a deficit. The sources say it plainly: antipsychotics are "most effective in positive symptoms" and "less useful for negative symptoms," with "little evidence that antipsychotics substantially improve negative or cognitive symptoms." That is not a treatment failure, it is the pharmacology working exactly as the mechanism predicts — and it is why CBT for psychosis, social skills training, supported employment and cognitive remediation are on the treatment list rather than being optional extras.
How do you tell an acute dystonic reaction, akathisia, tardive dyskinesia and NMS apart?
Timing and pattern separate them. Acute dystonia — sustained muscle contraction with abnormal posturing (oculogyric crisis, torticollis, trismus), within 48 hours in 50% of cases and 5 days in 90%; the emergency is laryngeal involvement, and a parenteral anticholinergic relieves it within 10 to 30 minutes. Akathisia — inner restlessness with pacing and rocking, onset “typically within 4 weeks of starting or increasing the medication dosage”; anticholinergics do not help, and it is linked to suicidal ideation, aggression and violence. Tardive dyskinesia — involuntary repetitive orofacial movements emerging months to years in and often persisting after the drug stops; anticholinergics are contraindicated and may worsen it, and the VMAT2 inhibitors valbenazine and deutetrabenazine are the FDA-approved treatments. NMS — a medical emergency over 24 to 72 hours requiring all three of dopamine-blocker exposure, severe rigidity and fever, plus two of diaphoresis, dysphagia, tremor, incontinence, altered consciousness, mutism, tachycardia, labile blood pressure, leukocytosis or elevated creatine kinase.
Are second-generation antipsychotics better than first-generation ones?
No — and the shortcut is worth unlearning. The honest answer is a trade-off: second-generation agents typically cause fewer extrapyramidal side effects and less tardive dyskinesia, while most of them — especially olanzapine and clozapine — carry a higher risk of metabolic syndrome, with its weight gain, hypertension, and raised lipids and glucose. The nursing text puts the same point mechanistically: "the risk for developing these movement disorders is the primary difference" between the classes, and "in other respects, the two classes have similar side effects and mechanisms of action." Second-generation drugs are not one interchangeable class either: in adults with multi-episode schizophrenia, a large network meta-analysis found efficacy differences between individual antipsychotics mostly gradual while side-effect differences were more marked, so the choice weighs the outcomes that matter most to this patient, their medical problems, and their preferences.

Sources

Reviewed by Hae Suk Lee, RN

Educational summary for nursing students. Scenarios are fictional teaching cases. Always verify against current guidelines and your institution's protocols before acting in practice. Not medical advice.

Bookmark LearnDrugs.com?

Your saved pages are kept in this browser. Add LearnDrugs.com to your browser’s bookmarks to get back to them in one click.

Drag this link to your bookmarks bar: LearnDrugs.com

Or press Ctrl + D to bookmark the page you’re on.